Health Care & Life Sciences » Pharmaceuticals | Catalyst Pharmaceutical Partners Inc.

Catalyst Pharmaceutical Partners Inc.

Catalyst Pharmaceutical Partners Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
102.6 M
Public Float
95.67 M

Profile

Address
355 Alhambra Circle
Coral Gables Florida 33134
United States
Employees -
Website http://www.catalystpharma.com
Updated 07/08/2019
Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on development and commercialization of prescription drugs targeting rare (orphan) neuromuscular and neurological diseases, including Lambert-Eaton Myasthenic Syndrome (LEMS), infantile spasms, and Tourette's disorder. The company was founded by McEnany J.

Financials

View All
Created with Highcharts 5.0.14Catalyst Pharmaceutical Partners Inc.Net Income. Fiscal year is January-December. All values USD Thousands.12 15412 15415 50915 50920 23320 23318 07218 07218 41218 41234 00334 003201320142015201620172018010k20k30k40k

Patrick J. McEnany
Chairman, President & Chief Executive Officer
David S. Tierney
Independent Director